$3.92
-0.51-11.51%
Pre-Market: 6:24 PM EDT
Comments
Loading...
Exagen Earnings Estimates, EPS & Revenue | NASDAQ:XGN | Benzinga
Exagen reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 12
EPS Estimate
$-0.240
Quarterly Revenue Estimate
$14.70M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$55.64M
Analyze the earnings history of Exagen using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| XGN | Exagen | -$0.19 | -$0.24 | — | — | $14.41M | $14.70M | — | — | 05/12/2025 | Get Alert |
| XGN | Exagen | -$0.31 | -$0.24 | -$0.20 | 16.67% | $13.77M | $13.85M | $13.65M | -1.41% | 03/11/2025 | Get Alert |
| XGN | Exagen | -$0.31 | -$0.29 | -$0.28 | 3.45% | $13.42M | $13.56M | $12.51M | -7.77% | 11/12/2024 | Get Alert |
| XGN | Exagen | -$0.28 | -$0.35 | -$0.16 | 54.29% | $14.14M | $13.13M | $15.06M | 14.73% | 08/05/2024 | Get Alert |
| XGN | Exagen | -$0.44 | -$0.36 | -$0.19 | 47.22% | $11.23M | $13.09M | $14.41M | 10.12% | 05/13/2024 | Get Alert |
| XGN | Exagen | -$0.83 | -$0.43 | -$0.31 | 27.91% | $12.84M | $11.56M | $13.77M | 19.07% | 03/18/2024 | Get Alert |
| XGN | Exagen | -$0.47 | -$0.46 | -$0.31 | 32.61% | $14.73M | $10.33M | $13.42M | 29.87% | 11/13/2023 | Get Alert |
| XGN | Exagen | -$0.78 | -$0.48 | -$0.28 | — | $8.96M | $10.97M | $14.14M | 28.90% | 08/07/2023 | Get Alert |
| XGN | Exagen | -$0.60 | -$0.56 | -$0.44 | 21.43% | $10.39M | $9.40M | $11.23M | 19.47% | 05/15/2023 | Get Alert |
| XGN | Exagen | -$0.42 | -$0.78 | -$0.51 | 34.62% | $12.69M | $8.66M | $12.84M | 48.23% | 03/20/2023 | Get Alert |
| XGN | Exagen | -$0.42 | -$0.73 | -$0.47 | 35.62% | $12.25M | $9.13M | $14.73M | 61.29% | 11/14/2022 | Get Alert |
| XGN | Exagen | -$0.38 | -$0.57 | -$0.78 | -36.84% | $12.77M | $12.04M | $8.96M | -25.56% | 08/04/2022 | Get Alert |
| XGN | Exagen | -$0.48 | -$0.61 | -$0.60 | 1.64% | $10.59M | $10.00M | $10.39M | 3.94% | 05/11/2022 | Get Alert |
| XGN | Exagen | -$0.27 | -$0.50 | -$0.42 | 16.00% | $12.67M | $11.80M | $12.69M | 7.53% | 03/22/2022 | Get Alert |
| XGN | Exagen | -$0.34 | -$0.46 | -$0.42 | 8.70% | $10.78M | $12.13M | $12.25M | 1.00% | 11/10/2021 | Get Alert |
| XGN | Exagen | -$0.27 | -$0.44 | -$0.38 | 13.64% | $8.95M | $11.48M | $12.77M | 11.25% | 08/09/2021 | Get Alert |
| XGN | Exagen | -$0.44 | -$0.47 | -$0.48 | -2.13% | $9.58M | $10.45M | $10.59M | 1.31% | 05/11/2021 | Get Alert |
| XGN | Exagen | -$0.27 | -$0.40 | -$0.27 | 32.50% | $10.21M | $10.76M | $12.67M | 17.73% | 03/16/2021 | Get Alert |
| XGN | Exagen | -$2.08 | -$0.48 | -$0.34 | 29.17% | $10.44M | $8.88M | $10.78M | 21.34% | 11/10/2020 | Get Alert |
| XGN | Exagen | — | -$0.76 | -$0.27 | 64.47% | — | $4.68M | $8.95M | 91.20% | 07/28/2020 | Get Alert |
| XGN | Exagen | — | -$0.49 | -$0.44 | 10.20% | $9.26M | $7.73M | $9.58M | 23.98% | 05/11/2020 | Get Alert |
Exagen (XGN) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-11 | $-0.20 | $-0.24 | 16.7 % |
| Q3 | 2024-11-12 | $-0.28 | $-0.29 | 3.45 % |
| Q2 | 2024-08-05 | $-0.16 | $-0.35 | 54.3 % |
| Q1 | 2024-05-13 | $-0.19 | $-0.36 | 47.2 % |
Exagen (XGN) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-11 | $13.66M | $13.85M | -1.41 % |
| Q3 | 2024-11-12 | $12.51M | $13.56M | -7.77 % |
| Q2 | 2024-08-05 | $15.06M | $13.13M | 14.7 % |
| Q1 | 2024-05-13 | $14.42M | $13.09M | 10.1 % |
FAQ
When is Exagen (NASDAQ:XGN) reporting earnings?
Exagen (XGN) is scheduled to report earnings on May 12, 2025. The last reported earnings were for reported on March 11, 2025 for Q4.
What were the latest earnings per share (EPS) for Exagen (NASDAQ:XGN)?
The Actual EPS was $-0.20, which beat the estimate of $-0.24.
What were Exagen’s (NASDAQ:XGN) revenues?
The Actual Revenue was $13.7M, which missed the estimate of $13.8M.
Browse earnings estimates, EPS, and revenue on all stocks.